A citation-based method for searching scientific literature

Lodewijk J A Toonen, Frank Rigo, Haico van Attikum, Willeke M C van Roon-Mom. Mol Ther Nucleic Acids 2017
Times Cited: 52



Sandro Alves, Isabel Nascimento-Ferreira, Gwennaëlle Auregan, Raymonde Hassig, Noëlle Dufour, Emmanuel Brouillet, Maria C Pedroso de Lima, Philippe Hantraye, Luís Pereira de Almeida, Nicole Déglon. PLoS One 2008
Times Cited: 106




List of shared articles



Times cited

Spinocerebellar ataxias: prospects and challenges for therapy development.
Tetsuo Ashizawa, Gülin Öz, Henry L Paulson. Nat Rev Neurol 2018
75

Oligonucleotide therapy mitigates disease in spinocerebellar ataxia type 3 mice.
Hayley S McLoughlin, Lauren R Moore, Ravi Chopra, Robert Komlo, Megan McKenzie, Kate G Blumenstein, Hien Zhao, Holly B Kordasiewicz, Vikram G Shakkottai, Henry L Paulson. Ann Neurol 2018
62

Gene Therapies for Polyglutamine Diseases.
Carlos A Matos, Vítor Carmona, Udaya-Geetha Vijayakumar, Sara Lopes, Patrícia Albuquerque, Mariana Conceição, Rui Jorge Nobre, Clévio Nóbrega, Luís Pereira de Almeida. Adv Exp Med Biol 2018
8



Polyglutamine spinocerebellar ataxias: emerging therapeutic targets.
Andreia Neves-Carvalho, Sara Duarte-Silva, Andreia Teixeira-Castro, Patrícia Maciel. Expert Opin Ther Targets 2020
3

Pathogenesis of SCA3 and implications for other polyglutamine diseases.
Hayley S McLoughlin, Lauren R Moore, Henry L Paulson. Neurobiol Dis 2020
32

Machado-Joseph disease/spinocerebellar ataxia type 3: lessons from disease pathogenesis and clues into therapy.
Carlos A Matos, Luís Pereira de Almeida, Clévio Nóbrega. J Neurochem 2019
39

Recent Advances in the Treatment of Cerebellar Disorders.
Hiroshi Mitoma, Mario Manto, Jordi Gandini. Brain Sci 2019
3


The Role of MicroRNAs in Spinocerebellar Ataxia Type 3.
Sybille Krauss, Bernd O Evert. J Mol Biol 2019
5


Development of an AAV-Based MicroRNA Gene Therapy to Treat Machado-Joseph Disease.
Raygene Martier, Marina Sogorb-Gonzalez, Janice Stricker-Shaver, Jeannette Hübener-Schmid, Sonay Keskin, Jiri Klima, Lodewijk J Toonen, Stefan Juhas, Jana Juhasova, Zdenka Ellederova,[...]. Mol Ther Methods Clin Dev 2019
18

Druggable genome screen identifies new regulators of the abundance and toxicity of ATXN3, the Spinocerebellar Ataxia type 3 disease protein.
Naila S Ashraf, Joanna R Sutton, Yemen Yang, Bedri Ranxhi, Kozeta Libohova, Emily D Shaw, Anna J Barget, Sokol V Todi, Henry L Paulson, Maria do Carmo Costa. Neurobiol Dis 2020
4

RNA Interference Therapy for Machado-Joseph Disease: Long-Term Safety Profile of Lentiviral Vectors Encoding Short Hairpin RNAs Targeting Mutant Ataxin-3.
Clévio Nóbrega, José Miguel Codêsso, Liliana Mendonça, Luís Pereira de Almeida. Hum Gene Ther 2019
7

Current Status of Gene Therapy Research in Polyglutamine Spinocerebellar Ataxias.
Ricardo Afonso-Reis, Inês T Afonso, Clévio Nóbrega. Int J Mol Sci 2021
2

Genetics, Mechanisms, and Therapeutic Progress in Polyglutamine Spinocerebellar Ataxias.
Ronald A M Buijsen, Lodewijk J A Toonen, Sarah L Gardiner, Willeke M C van Roon-Mom. Neurotherapeutics 2019
38

Recent therapeutic prospects for Machado-Joseph disease.
Maria do Carmo Costa. Curr Opin Neurol 2020
0